Search

Your search keyword '"Arthritis -- Drug therapy"' showing total 2,224 results
Start Over Descriptor "Arthritis -- Drug therapy"
2,224 results on '"Arthritis -- Drug therapy"'

2. Islamic Azad University Researchers Update Knowledge of Rheumatoid Arthritis (Optimized co-delivery of curcumin and methylprednisolone using polyvinyl alcohol-coated CuO nanoparticles for synergistic rheumatoid arthritis treatment)

Subjects
Methylprednisolone, Cuprite, Corticosteroids, Rheumatoid factor, Antirheumatic agents, Arthritis -- Drug therapy, Copper oxide, Physical fitness, Substance abuse -- Care and treatment, Health
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on rheumatoid arthritis is now available. According to news [...]

Published
2024

3. Findings from Zhejiang University Provides New Data about Rheumatoid Arthritis (A Cationic Hydrogel With Anti-il-17a-specific Nanobodies for Rheumatoid Arthritis Treatment Via Inhibition of Inflammatory Activities of Neutrophils)

Subjects
Medical research -- Reports, Medicine, Experimental -- Reports, Rheumatoid factor -- Reports, Antirheumatic agents -- Reports, Arthritis -- Drug therapy, Physical fitness -- Reports, Health
Abstract

2024 DEC 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Autoimmune Diseases and Conditions - Rheumatoid Arthritis is [...]

Published
2024

4. Findings from COMSATS University Islamabad Yields New Data on Drug Research (Anti-arthritic Studies of Ethnomedicine gaultheria Trichophylla Royle Extract and Salicylate-rich Fraction Using Complete Freud's Adjuvant-induced Rats: ...)

Subjects
Methyl salicylate, Arthritis -- Drug therapy, Physical fitness, Health
Abstract

2024 OCT 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Drug Research. According to news reporting out [...]

Published
2024

5. New Findings Reported from University of Verona Describe Advances in Rheumatoid Arthritis (Glucocorticoid sparing effect of Janus kinase inhibitors compared to biologic disease modifying anti-rheumatic drugs in rheumatoid arthritis, a ...)

Subjects
Corticosteroids -- Reports -- Comparative analysis, Rheumatoid factor -- Comparative analysis -- Reports, Diseases -- Drug therapy, Antirheumatic agents -- Comparative analysis -- Reports, Arthritis -- Drug therapy, Mutual fund industry -- Reports -- Comparative analysis, Physical fitness -- Comparative analysis -- Reports, Health
Abstract

2024 OCT 19 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on rheumatoid arthritis are discussed in a new report. According [...]

Published
2024

6. Researchers at School of Pharmaceutical Sciences Report New Data on Arthritis (Recent Advancements of Hyaluronic Acid Nanoscaffolds In Arthritis Management)

Subjects
Hyaluronic acid -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Antiarthritic agents -- Reports, Arthritis -- Drug therapy, Physical fitness -- Reports, Company business management, Health
Abstract

2024 SEP 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on Musculoskeletal Diseases and Conditions - Arthritis is now [...]

Published
2024

8. Data on Rheumatoid Arthritis Discussed by Researchers at Anhui Medical University (Viral Mimicking Polyplexes As Hierarchical Unpacking Vectors for Rheumatoid Arthritis Treatment)

Subjects
Rheumatoid factor, Antirheumatic agents, Arthritis -- Drug therapy, Physical fitness, Health
Abstract

2024 JUL 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Autoimmune Diseases and Conditions - Rheumatoid Arthritis have been [...]

Published
2024

9. Reports from Anhui Medical University Describe Recent Advances in Rheumatoid Arthritis (Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization)

Subjects
Lipids, Target marketing, Rheumatoid factor, Antiarthritic agents, Arthritis -- Drug therapy, Medical colleges, Physical fitness, Autoimmune diseases -- Drug therapy, Health
Abstract

2024 JUL 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on rheumatoid arthritis are presented in a new report. According [...]

Published
2024

10. Kevzara Approved for Active Polyarticular Juvenile Idiopathic Arthritis

Author

Park, Brian

Subjects
United States. Food and Drug Administration, Rheumatoid factor, Arthritis -- Drug therapy, Drug approval, Health, Kevzara (Medication)
Abstract

The Food and Drug Administration (FDA) has approved Kevzara[sup.®] (sarilumab), an interleukin-6 receptor antagonist, for the treatment of patients weighing 63kg or more with active polyarticular juvenile idiopathic arthritis (pJIA). [...]

Published
2024

11. Investigators from Sun Yat-sen University Release New Data on Rheumatoid Arthritis (In Situ Polymeric Nanomicelle-generating Dissolving Microneedle Patch for Enhanced Transdermal Methotrexate Delivery In Rheumatoid Arthritis Treatment)

Subjects
Medical research -- Reports, Medicine, Experimental -- Reports, Rheumatoid factor -- Reports, Arthritis -- Drug therapy, Methotrexate -- Dosage and administration, Transdermal medication -- Reports, Physical fitness -- Reports, Health
Abstract

2024 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Autoimmune Diseases and Conditions - Rheumatoid Arthritis is the [...]

Published
2024

12. Simlandi, an Interchangeable Biosimilar to Humira, Now Available

Author

Park, Brian

Subjects
Rheumatoid factor, Generic drugs, Arthritis -- Drug therapy, Tumor necrosis factor, Health, Simlandi (Medication)
Abstract

Simlandi[sup.®] (adalimumab-ryvk) injection, a citrate-free, high-concentration, interchangeable biosimilar to https://www.empr.com/drug/humira/ [sup.®] (adalimumab), has been made available by Teva and Alvotech. Simlandi is an interchangeable biosimilar and can be substituted for [...]

Published
2024

13. Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA (guselkumab)

Subjects
Tremfya (Medication), Psoriasis -- Drug therapy, Medical research, Medicine, Experimental, Pediatrics, Arthritis -- Drug therapy, Children -- Health aspects, Adalimumab, Drug approval, Johnson & Johnson
Abstract

Applications filed for TREMFYAto treat children with moderate to severe plaque psoriasis and active juvenile psoriatic arthritis SPRING HOUSE, Pa., Dec. 2, 2024 /PRNewswire/ -- Johnson & Johnson today announced [...]

Published
2024

14. PEGylated Proteins Market Set to Reach USD 19.1 Billion by 2031, Driven by Advancements in Drug Delivery: - Market Research Intellect

Subjects
Drugs -- Vehicles, Rheumatoid factor -- Forecasts and trends, Antiarthritic agents -- Forecasts and trends, Chronic diseases -- Drug therapy, Arthritis -- Drug therapy, Marketing research -- Forecasts and trends, Proteins -- Forecasts and trends, Drug delivery systems -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid arthritis. [...]

Published
2024

15. Arthritis Treatment Specialist in San Jose, CA Introduces Innovative Approach to Mitigate Arthritis Symptoms and Enhance Joint Stability

Subjects
Antiarthritic agents -- Methods, Arthritis -- Drug therapy, Business, Business, international
Abstract

M2 PRESSWIRE-November 7, 2024-: Arthritis Treatment Specialist in San Jose, CA Introduces Innovative Approach to Mitigate Arthritis Symptoms and Enhance Joint Stability (C)1994-2024 M2 COMMUNICATIONS RDATE:07112024 Scott Lamb, an expert [...]

Published
2024

16. Key patient considerations for the usage of intravenous and subcutaneous biologies

Subjects
Ulcerative colitis -- Drug therapy, Rheumatoid factor -- Usage, Antiarthritic agents -- Usage, Arthritis -- Drug therapy, Drug approval -- Usage, Tumor necrosis factor -- Usage, Business, Health care industry
Abstract

Biologies have transformed the treatment of autoimmune diseases sueh as rheumatoid arthritis, psoriasis, Crohn's disease and ulcerative colitis. Jill Zouzoulas, M.D., a rheumatologist at Tryon Medieal Partners in Charlotte, North [...]

Published
2024

18. Researcher at Shenyang Pharmaceutical University Has Published New Data on Rheumatoid Arthritis (Ionic Liquid Transdermal Patches of Two Active Ingredients Based on Semi-Ionic Hydrogen Bonding for Rheumatoid Arthritis Treatment)

Subjects
Rheumatoid factor, Hydrogen, Antirheumatic agents, Arthritis -- Drug therapy, Transdermal medication, Physical fitness, Health
Abstract

2024 APR 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on rheumatoid arthritis have been presented. According to news reporting [...]

Published
2024

19. Pet owners blaming Zoetis arthritis drug for pet illnesses, WSJ says

Subjects
Antiarthritic agents, Arthritis -- Drug therapy, Business, News, opinion and commentary
Abstract

Librela and a similar treatment for cats and dogs are an important franchise for maker Zoetis, but 'now they are at the center of a medical mystery' as some pet [...]

Published
2024

20. Prevalence of Arthritis in US Adults 18.9% in 2022

Subjects
Arthritis -- Drug therapy, Health
Abstract

HealthDay News — The age-adjusted prevalence of adults with arthritis was 18.9% in 2022 in the US, according to a February data brief published by the National Center for Health [...]

Published
2024

21. Researchers from Qinghai University Describe Findings in Rheumatoid Arthritis (Efficacy and Mechanisms of Qianghuo Shengshi Tang In Rheumatoid Arthritis: a Network Pharmacology and Experimental Study)

Subjects
Medical research, Medicine, Experimental, Rheumatoid factor, Antiarthritic agents, Pharmacology, Arthritis -- Drug therapy, Health
Abstract

2025 JAN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in Autoimmune Diseases and Conditions - Rheumatoid Arthritis. According [...]

Published
2025

22. Findings from Chongqing Medical and Pharmaceutical College in Rheumatoid Arthritis Reported (Systematic pharmacology-based strategy to investigate the mechanism of beta-sitosterol for the treatment of rheumarthritis)

Subjects
Phytosterols -- Reports, Rheumatoid factor -- Reports, Antiarthritic agents -- Reports, Pharmacology -- Reports, Arthritis -- Drug therapy, Health
Abstract

2024 DEC 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on rheumatoid arthritis. According to news reporting originating from [...]

Published
2024

25. Studies from Maastricht University Provide New Data on Rheumatoid Arthritis (The Impact of Health Literacy: Associations With Disease Activity and Medication Prescription In Patients With Rheumatoid Arthritis)

Subjects
Medical research, Medicine, Experimental, Rheumatoid factor, Antiarthritic agents, Diseases -- Drug therapy -- Netherlands, Arthritis -- Drug therapy
Abstract

2024 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Autoimmune Diseases and Conditions - Rheumatoid Arthritis is now [...]

Published
2024

26. Reports Outline Arthritis Study Findings from University of Cape Town (South African Rheumatism and Arthritis Association 2024 Guidelines for the Use of Biologic and Targeted Synthetic Disease-modifying Antirheumatic Drugs)

Subjects
University of Cape Town, Medical research -- Usage, Medicine, Experimental -- Usage, Diseases -- Drug therapy -- South Africa, Drugs -- Usage, Antirheumatic agents -- Usage, Arthritis -- Drug therapy
Abstract

2024 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in Musculoskeletal Diseases and Conditions - Arthritis. According to [...]

Published
2024

27. China Academy of Chinese Medical Sciences Researchers Advance Knowledge in Lung Diseases and Conditions (Efficacy and safety of integrated traditional Chinese and Western medicine for rheumatoid arthritis-interstitial lung disease: A systematic ...)

Subjects
Medical research, Medicine, Experimental, Lung diseases -- Drug therapy, Rheumatoid factor, Medicine, Chinese, Antirheumatic agents, Arthritis -- Drug therapy
Abstract

2024 NOV 11 (NewsRx) -- By a News Reporter-Staff News Editor at Respiratory Therapeutics Week -- Researchers detail new data in lung diseases and conditions. According to news reporting out [...]

Published
2024

28. New COVID-19 Research from University of Medicine and Pharmacy Described (Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review)

Subjects
Communicable diseases -- Drug therapy, Rheumatoid factor, Immunotherapy, Arthritis -- Drug therapy, Medical colleges, Pharmacy, Severe acute respiratory syndrome -- Drug therapy, Business, Health, Health care industry
Abstract

2024 NOV 10 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Researchers detail new data in COVID-19. According to news reporting [...]

Published
2024

29. Investigators from Jilin University Zero in on Rheumatoid Arthritis (Fluorinated Polyamidoamine Dendrimer-mediated Mir-23b Delivery for the Treatment of Experimental Rheumatoid Arthritis In Rats)

Subjects
Rheumatoid factor, Antiarthritic agents, Arthritis -- Drug therapy, Apoptosis, Health
Abstract

2024 NOV 8 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Autoimmune Diseases and Conditions - Rheumatoid Arthritis. According [...]

Published
2024

30. UCB Announces U.S. FDA Approvals for BIMZELX (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis

Subjects
Bimzelx (Medication), Psoriasis -- Drug therapy, Judicial opinions, Governmental investigations, Arthritis -- Drug therapy, Drug approval, Tumor necrosis factor
Abstract

With three new indications, BIMZELX(bimekizumab-bkzx) is the first and only IL-17A and IL-17F inhibitor approved in the U.S. for the treatment of four chronic immune-mediated inflammatory diseases Approval in active [...]

Published
2024

31. Mallinckrodt Announces Publication of Human Factors Studies and Arthritis Foundation Ease of Use Certification of Acthar Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector

Subjects
Arthritis -- Drug therapy, Drug approval, ACTH -- Dosage and administration, Mallinckrodt PLC
Abstract

-- Findings from nine human factors studies, assessing design and user interface, suggest SelfJect functions as an effective delivery device when used as intended[sup.1] -- -- The SelfJect delivery device [...]

Published
2024

32. Immune cell regulator discovery could lead to treatments for arthritis and severe COVID

Subjects
Medical research, Medicine, Experimental, Inflammation -- Drug therapy, Antiarthritic agents, Infection -- Drug therapy, Arthritis -- Drug therapy, Business, international
Abstract

London: University of Exeter has issued the following news release: The discovery of a new regulator affecting immune cells could lead to new treatments to reduce inflammation in diseases including [...]

Published
2024

33. Immune cell regulator discovery could lead to treatments for arthritis and severe COVID

Subjects
Antiarthritic agents, Arthritis -- Drug therapy, Business, Business, international, University of Aberdeen
Abstract

M2 PRESSWIRE-August 15, 2024-: Immune cell regulator discovery could lead to treatments for arthritis and severe COVID (C)1994-2024 M2 COMMUNICATIONS RDATE:15082024 The discovery of a new regulator affecting immune cells [...]

Published
2024

34. Celltrion USA announces incorporation of adalimumab-aaty, a Humira biosimilar, to the Costco Member Prescription Program

Subjects
United States. Food and Drug Administration, Psoriasis -- Drug therapy, Ulcerative colitis -- Drug therapy, Rheumatoid factor, Arthritis -- Drug therapy, Adalimumab, Drug approval, Warehouse stores, Business, News, opinion and commentary, Yuflyma (Medication), Humira (Medication)
Abstract

Adalimumab-aaty was first approved by the Food and Drug Administration on May 23, 2023 and became commercially available among key distributors across the U.S. on July 2, 2023 Adalimumab-aaty's inclusion [...]

Published
2024

37. Reports from Nankai University Provide New Insights into Rheumatoid Arthritis (Microenvironment-activatable Probe for Precise Nir-ii Monitoring and Synergistic Immunotherapy In Rheumatoid Arthritis)

Subjects
Medical research, Medicine, Experimental, Rheumatoid factor, Immunotherapy, Arthritis -- Drug therapy, Health, Nankai University
Abstract

2024 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Current study results on Autoimmune Diseases and Conditions - Rheumatoid Arthritis have been published. According [...]

Published
2024

38. Studies from Kunming Medical University Yield New Data on Rheumatoid Arthritis (Risk of Active Tuberculosis During Anti-TNF-a Inhibitor Use to Treat Rheumatoid Arthritis: A Meta-Analysis of Randomized Controlled Trials)

Subjects
Rheumatoid factor, Antiarthritic agents, Tuberculosis -- Drug therapy, Arthritis -- Drug therapy, Tumor necrosis factor, Evidence-based medicine, Health
Abstract

2024 SEP 24 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Investigators publish new report on rheumatoid arthritis. According to news reporting out of [...]

Published
2024

39. University of New Mexico School of Medicine Researcher Furthers Understanding of Rheumatoid Arthritis (Rheumatoid arthritis associated vasculitis: a rare entity; case and review)

Subjects
Vasculitis -- Drug therapy, Rheumatoid factor, Antiarthritic agents, Arthritis -- Drug therapy, Medical colleges, Health
Abstract

2024 SEP 20 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- New research on rheumatoid arthritis is the subject of a new report. According [...]

Published
2024

40. SRM Institute of Science and Technology Reports Findings in Rheumatoid Arthritis (Computational drug repositioning for IL6 triggered JAK3 in rheumatoid arthritis using FDA database)

Subjects
Medical research -- Reports, Medicine, Experimental -- Reports, Rheumatoid factor -- Reports, Antiarthritic agents -- Reports, Arthritis -- Drug therapy, Computers
Abstract

2024 AUG 27 (VerticalNews) -- By a News Reporter-Staff News Editor at Information Technology Newsweekly -- New research on Autoimmune Diseases and Conditions - Rheumatoid Arthritis is the subject of [...]

Published
2024

41. Hacettepe University Faculty of Medicine Researcher Focuses on Arthritis (Rhupus syndrome in children: A multi-center retrospective cohort study and literature review)

Subjects
Medical research -- Analysis, Medicine, Experimental -- Analysis, Pediatrics -- Analysis, Antiarthritic agents -- Analysis, Arthritis -- Drug therapy, Children -- Health aspects, College teachers -- Analysis, Health, Hacettepe University
Abstract

2024 AUG 23 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on arthritis are presented in a new report. According to news [...]

Published
2024

42. University of Queensland Researchers Release New Study Findings on Rheumatoid Arthritis (A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases)

Subjects
Medical research -- Analysis -- Reports, Medicine, Experimental -- Analysis -- Reports, Rheumatoid factor -- Reports -- Analysis, Medical records -- Analysis -- Reports, Databases -- Reports -- Analysis, Arthritis -- Drug therapy, CD-ROM catalog, Database, CD-ROM database, Health, University of Queensland -- Reports
Abstract

2024 AUG 9 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on rheumatoid arthritis. According to news originating from the [...]

Published
2024

43. Researchers at Pusan National University School of Medicine Have Published New Data on Rheumatoid Arthritis (Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line ...)

Subjects
Tumors -- Drug therapy, Rheumatoid factor, Antiarthritic agents, Antitubercular agents, Tuberculosis -- Drug therapy, Arthritis -- Drug therapy, Adalimumab, Tumor necrosis factor, Necrosis -- Drug therapy, Health, Drug therapy
Abstract

2024 AUG 6 (NewsRx) -- By a News Reporter-Staff News Editor at TB & Outbreaks Week -- Current study results on rheumatoid arthritis have been published. According to news reporting [...]

Published
2024

44. Institute of Materia Medica Researcher Has Published New Study Findings on Rheumatoid Arthritis (Exploring the Mechanism of Topical Application of Clematis Florida in the Treatment of Rheumatoid Arthritis through Network Pharmacology and ...)

Subjects
Rheumatoid factor -- Reports, Antiarthritic agents -- Reports, Medicine, Botanic -- Reports, Arthritis -- Drug therapy, Medicine, Herbal -- Reports, Health
Abstract

2024 AUG 2 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on rheumatoid arthritis have been published. According to news reporting [...]

Published
2024

45. How to Deal with Arthritis: A range of medications and management options can help to keep an active sporthorse comfortable and competing

Subjects
Phenylbutazone -- Methods, Antiarthritic agents -- Methods, Arthritis -- Drug therapy, Company business management, Sports and fitness
Abstract

Q: My 14-year-old hunter experiences mild lameness before he's warmed up, and our veterinarian has diagnosed minor arthritis in the left foreleg. He prescribed phenylbutazone (bute) and says that's all [...]

Published
2023

46. SetPoint Medical Announces Positive Topline Results from Landmark RESET-RA Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis

Subjects
Rheumatoid factor, Patient compliance, Health care industry, Antirheumatic agents, Arthritis -- Drug therapy, Health care industry, General interest, News, opinion and commentary
Abstract

VALENCIA: SETPOINT MEDICAL has issued the following news release: SetPoint Medical, a clinical-stage healthcare company dedicated to people living with chronic autoimmune diseases, today announced positive topline results from the [...]

Published
2024

47. SetPoint Medical Announces Positive Topline Results from Landmark RESET-RA Study Evaluating Neuroimmune Modulation for the Treatment of Rheumatoid Arthritis

Subjects
Rheumatoid factor, Patient compliance, Tofacitinib, Health care industry, Antirheumatic agents, Arthritis -- Drug therapy, Health care industry, Business, Business, international
Abstract

The SetPoint System is the first neuroimmune modulation device to demonstrate a clinical benefit in adults living with moderate-to-severe rheumatoid arthritis Study results will be presented at upcoming medical meetings [...]

Published
2024

49. Celon Pharma Announces Results of Phase II clinical trial for CPL' 116, a JAK/ROCK dual inhibitor in the treatment of Rheumatoid Arthritis (RA)

Subjects
Rheumatoid factor, Antirheumatic agents -- Product development, Arthritis -- Drug therapy, Clinical trials, Banking, finance and accounting industries, Business
Abstract

KIELPIN, Poland, June 17, 2024 (GLOBE NEWSWIRE) -- Celon Pharma S.A. (CLN.WA) today announced the successful completion of a Phase 2 trial a JAK/ROCK dual inhibitor in the treatment of [...]

Published
2024

50. Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis

Subjects
Rheumatoid factor -- Health aspects, Autoimmunity -- Health aspects, B cells -- Health aspects, Arthritis -- Drug therapy, Banking, finance and accounting industries, Business
Abstract

MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of MRT-6160 Phase 1 SAD/MAD study anticipated in [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results